10 min listen
The MDS sessions: clinical trial participation, endpoints & approvals
FromVJHemOnc Podcast
ratings:
Length:
44 minutes
Released:
Nov 17, 2020
Format:
Podcast episode
Description
Myelodysplastic syndromes (MDS) represent a range of disorders characterized by morphologic dysplasia, cytopenias, and a risk of progression to acute...
The post The MDS sessions: clinical trial participation, endpoints & approvals appeared first on VJHemOnc.
The post The MDS sessions: clinical trial participation, endpoints & approvals appeared first on VJHemOnc.
Released:
Nov 17, 2020
Format:
Podcast episode
Titles in the series (100)
Myeloma 2017 day 1 highlights: immunotherapy advances, a new MM subtype and liquid biopsies: Fantastic advances in immunotherapy, including CAR T-cells, bispecific antibodies and potential immunotherapy combinations, were presented at the Myeloma 2017 meeting... by VJHemOnc Podcast